H4CBD: effects, the ban in France and the H4-CBD saliva test
By the Golden High teamUpdated 9 October 202610 min read
Novel cannabinoids
H4CBD, or H4-CBD, is a CBD that has been hydrogenated in the lab: a molecule chemists have known since 1940, sold for a while in CBD shops as flowers, resins and vapes, and in France classed as a controlled drug since 3 June 2024 by decision of the ANSM (the French medicines agency). Producing, selling and using it are prohibited there. This article describes the situation in France: here's where H4CBD comes from, what we know about its effects, what the ban changes, and what you need to know about saliva tests.
Amnesia Delta-P 12 %
Our most popular flower: a moderate, clearly stated level and a lemony profile. Below 0.3% THC, lab-tested.
From4,90 €View product →
Gelato Delta-P 10 %
The entry point to the Delta-P range: 10%, a sweet, creamy profile, for starting low.
From4,90 €View product →The definition
What is H4CBD? A hydrogenated CBD.
H4CBD starts from CBD, cannabidiol, which is extracted from hemp. In the lab, four hydrogen atoms are added to saturate its two double bonds: that's what the “H4” stands for. The result doesn't exist in the plant. It's a semi-synthetic cannabinoid, the term the ANSM uses for natural substances that have been chemically modified.
Its name varies from one source to the next. The ANSM and scientific papers call it tetrahydrocannabidiol; in shops you'll also see “hexahydrocannabidiol”, “H4 CBD”, “CBD H4” or “hydrogenated CBD”. All of these names mean the same thing. Don't confuse it with H2-CBD (dihydrocannabidiol), another hydrogenated form, listed in France on the same day.
From 1940 to CBD shops
An old molecule, a recent market.
H4CBD isn't an invention of the 2020s. Chemists have known it since 1940, as toxicologists at the University of Bern point out in a 2025 study. It stayed a laboratory curiosity for eighty years, until the HHC ban opened up a market for it.
1940
Hydrogenated CBD is described for the first time.
2006
An Israeli team hydrogenates CBD and measures how these derivatives bind to the CB1 receptor.
2022-2023
H4-CBD shows up in European seizures, after delta-8-THC and HHC. In France, it's pushed as a replacement when HHC is listed, on 13 June 2023.
3 June 2024
H4-CBD becomes a controlled drug in France, along with H2-CBD and the derivatives of the benzo[c]chromene core.
6 June 2025
The Conseil d'État, France's highest administrative court, rejects the challenges brought by CBD businesses against the listing.
The previous episode, the HHC one, is told in What is HHC, and why it's banned in France.
What the sources say
H4CBD: what is actually documented.
There isn't much data on H4CBD, and none of it comes from a clinical trial. Here are the most solid reference points, all listed at the bottom of the page.
Journal of Medicinal Chemistry · 2006
Researchers hydrogenate CBD and find, “surprisingly” in their words, that these derivatives bind well to the CB1 receptor, the one THC acts through, and that they don't have the same biological activity as the CBD they started from.
Drug Testing and Analysis · 2025
The University of Bern identifies the urinary metabolites of H4CBD. The authors mention a weak affinity for CB1 and consider its psychoactive nature uncertain, since user accounts are “mixed”.
Journal of Forensic Sciences · 2024
In Denmark, 15% of the cannabis products seized between 2018 and 2023 contained a semi-synthetic cannabinoid. H4-CBD comes second, behind HHC: 4% of samples.
Forensic Science International · 2026
Out of 26 products marketed as “legal” and bought from Italian websites between 2024 and 2026, H4CBD is the most common semi-synthetic (23.1%). All of them contained THC, and 92.3% were mislabelled.
ANSM and Anses · June 2025
Several hundred poisonings recorded in France since early 2024 among people who had used products presented as CBD, according to the ANSM and Anses (the French health and safety agency). H4-CBD is named among the molecules involved, along with HHC, HHC-O and MDMB-PINACA.
Two takeaways. First, hydrogenating CBD doesn't give you “a better CBD”: it changes the way it acts. Second, a lot of H4CBD was sold without being declared, in products whose label said something else.
H4CBD: effects, reviews, forums
H4CBD effects: conflicting accounts.
Browse a forum or a page of H4CBD reviews and you'll read everything and its opposite: “nothing more than CBD” for some, a clear high for others. The Swiss researchers note the same thing. One likely explanation: lab analyses show these products often contained something other than what was stated. Two people who “try H4CBD” aren't necessarily using the same thing.
What users reported
A stronger effect than CBD for some, no notable effect for others. The Bern toxicologists describe the accounts as “mixed” and don't settle the question.
What the French authorities say
For the Conseil d'État, H4-CBD and H2-CBD “have a cannabinergic psychoactive profile”. For all the molecules listed in 2024, the ANSM describes effects that mimic those of THC.
- Vomiting, loss of consciousness, seizures.
- Anxiety that can go as far as a panic attack, paranoia.
- Rapid heart rate, high blood pressure, chest pain.
- Risk of dependence with repeated use.
List of the immediate effects cited by the ANSM for the cannabinoids listed in France on 3 June 2024, H4-CBD included. The agency adds that the more concentrated the product, the more severe the complications can be.
The H4CBD ban
In France, H4CBD has been banned since 3 June 2024.
H4-CBD is classed as a controlled drug in France. The decision was taken by the ANSM's director general on 22 May 2024, published on the 24th, and came into force on 3 June 2024. Unlike THCP or HHCPO, which are covered by a chemical-family definition, H4-CBD and H2-CBD are listed by name. Its status varies from country to country: we're only describing the French case here.
The reasoning fits in one sentence of the decision: psychoactive effects similar to those of delta-9-THC, a potential for abuse and dependence, and immediate health risks. The agency says it received reports of serious effects from France's addiction monitoring centres.
- What is banned in France: production, sale and use, according to the ANSM. Flower, resin, oil, e-liquid or gummies: the form makes no difference.
- No tolerated threshold: the 0.3% exception applies to the THC in hemp products, not to H4-CBD.
- Challenges rejected: asked to rule by CBD businesses, the Conseil d'État upheld the listing on 6 June 2025.
Key takeaway: any “H4CBD resin”, “H4CBD hash” or “H4CBD flower” sold in France today is a controlled drug. And despite what you can still read online about “H4 CBD being legalised”, nothing in the published French decisions points that way.
H4CBD and the saliva test
Saliva test: almost no data.
The roadside saliva test doesn't look for H4CBD. In France, for the cannabis family, it targets delta-9-THC. So the real question is twofold: can H4CBD make this test react because it looks similar, and did the product you used contain THC?
- Cross-reactivity: we found no published study that tests H4CBD on saliva screening devices. For HHC, results vary from one test to another. For H4CBD, nobody knows.
- Hidden THC: in the 2026 Italian study, every product analysed contained THC, with a median of 0.4%. A product sold as H4CBD can therefore turn a test positive because of the THC it contains.
- Confirmation analysis: it's done in a laboratory, by mass spectrometry. The urinary metabolites of H4CBD are now described in the literature.
Beyond the test itself, driving after using a controlled drug is a criminal offence in France, punishable by three years in prison and a €9,000 fine under article L235-1 of the French Highway Code. And H4-CBD is a controlled drug there. We've explained how screening works in HHC and saliva tests: what roadside testing really detects.
You won't find any trick here for “passing” a test. The only rule that holds: if you've used, you don't drive.
HHC vs H4CBD, THCP or H4CBD
HHC, THCP or H4CBD: three molecules, one fate.
| H4CBD | HHC | THCP | |
|---|---|---|---|
| Starting molecule | Hydrogenated CBD | Hydrogenated THC | THC with a 7-carbon side chain |
| CB1 binding | Observed in 2006, described as weak in 2025 | THC-like activity | Very high in vitro (Ki 1.2 nM) |
| Status in France | Controlled drug since 03/06/2024, listed by name | Controlled drug since 13/06/2023 | Controlled drug since 03/06/2024 |
| Reported effects | Variable, mixed accounts | Close to THC | Close to THC, at a much lower dose |
“THCP or H4CBD”: the question came up a lot when both were on sale. In France it no longer applies, since both have been listed since the same day. The detail on the first is in THCP: effects, risks and legal status, and the big picture is in HHC, THC, THCP, Delta-P: the comparison.
Where we stand
Golden High doesn't sell H4CBD.
No Golden High product contains H4CBD, H2-CBD, HHC or THCP. The shop only offers its Delta-P range, based on CBDX: products below 0.3% THC, lab-tested, with a stated level on every product page. Delta-P isn't another name for H4CBD. It's all explained on our Delta-P page.
Read the ingredients
If a label mentions H4CBD, H2-CBD, HHC or THCP, the product is a controlled drug in France. Walk away.
Pick a stated level
In the Delta-P flowers collection, you can start at 10% with Gelato Delta-P or at 12% with Amnesia Delta-P.
Start low
One or two puffs, then you wait. Adults only, and never before driving.
Your questions
What people ask us about H4CBD.
Is H4CBD banned in France?
Yes. In France, H4-CBD is classed as a controlled drug by an ANSM decision of 22 May 2024, in force since 3 June 2024. Producing, selling and using it are prohibited, whatever form the product takes. This article describes the situation in France; its status varies from country to country, so check the rules where you live.
What is H4 CBD?
A CBD hydrogenated in the lab, also called tetrahydrocannabidiol. It's a semi-synthetic cannabinoid: it's made from CBD but doesn't exist in the plant.
What are the effects of H4CBD?
User accounts are mixed, from “nothing more than CBD” to a clear high. For the molecules listed in France in 2024, the ANSM describes effects that mimic those of THC, with side effects that are sometimes serious.
Does H4CBD show up on a saliva test?
In France, the roadside saliva test targets THC, and no published study says whether it reacts to H4CBD. On the other hand, products sold as H4CBD often contained THC. Driving after using a controlled drug is a criminal offence under French law.
HHC vs H4CBD: what's the difference?
HHC is a hydrogenated THC, H4CBD a hydrogenated CBD. Both are made in a lab and classed as controlled drugs in France: HHC since 13 June 2023, H4CBD since 3 June 2024.
THCP or H4CBD: which is stronger?
In the lab, THCP binds to the CB1 receptor far more strongly than H4CBD. The comparison has no practical point in France any more: both have been classed as controlled drugs since 3 June 2024.
Will H4CBD be legalised in France?
Nothing suggests so. On 6 June 2025 the Conseil d'État, France's highest administrative court, rejected the challenges brought against its listing, and the ANSM repeated in 2025 that products containing H4-CBD are controlled drugs.
Does Golden High sell H4CBD resin?
No. Golden High doesn't sell any H4CBD product. The shop only offers its Delta-P range, based on CBDX, below 0.3% THC and lab-tested.
Sources
The references cited in this article.
- ANSM (2024, updated in 2025). The ANSM adds new cannabinoids to the list of controlled drugs and text of the decision of 22/05/2024 amending the list of substances classed as controlled drugs (in French).
- Conseil d'État (France's highest administrative court), 6 June 2025, no. 494779. Decision published on ArianeWeb (in French).
- ANSM and Anses (2025). Rise in poisonings caused by CBD-based products containing other substances (in French).
- Journal of Medicinal Chemistry (2006). New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.
- Drug Testing and Analysis (2025). Identification of Tetrahydrocannabidiol Metabolites in Human Urine.
- Journal of Forensic Sciences (2024). Emergence of semi-synthetic cannabinoids in cannabis products seized in Eastern Denmark over a 6-year period; Forensic Science International (2026), Forensic profiling of synthetic and semi-synthetic cannabinoids in legal cannabis products in Italy.
- Légifrance. French Highway Code, articles L235-1 to L235-5: driving after using substances or plants classed as controlled drugs (in French).
